Acrivon Therapeutics Inc (NASDAQ:ACRV) shares are trading higher. The company on Tuesday announced $130 million in private placement financing. What Happened: Acrivon Therapeutics has entered into a securities purchase agreement to issue and sell 8.235 million shares of its common stock at a price of $8.50 per share, as well as pre-funded warrants to purchase up to 7.06 million shares through a private investment in public equity (PIPE) financing. The clinical stage biopharmaceutical company said it anticipates approximately $130 million in gross proceeds from the oversubscribed PIPE. The closing of the financing is ...